Oxford/AstraZeneca study supports UK decision to delay second doses
3 Feb, 2021 | 01:47h | UTCOxford/AstraZeneca study supports UK decision to delay second doses – Financial Times
Original study (preprint): Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
See also: Single dose of AstraZeneca vaccine could cut transmission by 67% – The Guardian AND Oxford vaccine could substantially cut spread – BBC
Commentary on Twitter (thread – click for more)
NEW: fresh data from trials in Brazil, South Africa and the UK shows the Oxford/AstraZeneca vaccine is highly effective with a 12 week gap between doses.
Efficacy is in fact much higher with a 12 week interval than a shorter gap
Story by @donatopmancini: https://t.co/PK4NHhGHeH pic.twitter.com/W3urxSECKL
— John Burn-Murdoch (@jburnmurdoch) February 2, 2021